Chicago Rivet & Machine(CVR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CVR Chicago Rivet & Machine

Market Closed 12-12 16:00:00 EST

14.40

+0.53

+3.84%

盘后14.40

+0.000.00%

18:44 EST

High14.75	Low13.75	Vol6.51K
Open13.93	D1 Closing13.86	Amplitude7.21%
Mkt Cap13.91M	Tradable Cap10.75M	Total Shares966.13K
T/O92.48K	T/O Rate0.87%	Tradable Shares746.83K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CVR","market":"US","secType":"STK","nameCN":"Chicago Rivet & Machine","latestPrice":14.395,"timestamp":1765573200000,"preClose":13.8627,"halted":0,"volume":6508,"hourTrading":{"tag":"盘后","latestPrice":14.395,"preClose":14.395,"latestTime":"18:44 EST","volume":4,"amount":58.19,"timestamp":1765583065507},"delay":0,"floatShares":746827,"shares":966132,"eps":-3.663593,"marketStatus":"Market Closed","change":0.5323,"latestTime":"12-12 16:00:00 EST","open":13.93,"high":14.75,"low":13.75,"amount":92476.551884,"amplitude":0.072136,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.663593,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":13.8627,"dividendRate":0.008336,"preHourTrading":{"tag":"盘前","latestPrice":13.25,"preClose":13.8627,"latestTime":"08:33 EST","volume":75,"amount":993.75,"timestamp":1765546390742},"postHourTrading":{"tag":"盘后","latestPrice":14.395,"preClose":14.395,"latestTime":"18:44 EST","volume":4,"amount":58.19,"timestamp":1765583065507},"volumeRatio":1.1925966386088334},"requestUrl":"/m/hq/s/CVR/wiki","defaultTab":"wiki","newsList":[{"id":"2590750062","title":"Is CVR Energy (NYSE:CVI) A Risky Investment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590750062","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590750062?lang=en_us&edition=fundamental","pubTime":"2025-12-12 22:38","pubTimestamp":1765550319,"startTime":"0","endTime":"0","summary":"Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/1033000-choice1-main-header/1585186680256","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/1033000-choice1-main-header/1585186680256"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-cvi/cvr-energy/news/is-cvr-energy-nysecvi-a-risky-investment","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-cvi/cvr-energy/news/is-cvr-energy-nysecvi-a-risky-investment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4161","BK4138","NYSE","CVI","CVR","EBIT"],"gpt_icon":0},{"id":"2584529954","title":"Chicago Rivet & Machine Maintains Quarterly Dividend at $0.03 a Share, Payable Dec. 19 to Shareholders of Record as of Dec. 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2584529954","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584529954?lang=en_us&edition=fundamental","pubTime":"2025-11-19 00:43","pubTimestamp":1763484207,"startTime":"0","endTime":"0","summary":"Chicago Rivet & Machine Maintains Quarterly Dividend at $0.03 a Share, Payable Dec. 19 to Shareholders of Record as of Dec. 5","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CVR","BK4161"],"gpt_icon":0},{"id":"2584366954","title":"Chicago Rivet & Machine Co. announces $0.03 per share quarterly dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2584366954","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584366954?lang=en_us&edition=fundamental","pubTime":"2025-11-19 00:39","pubTimestamp":1763483947,"startTime":"0","endTime":"0","summary":"Chicago Rivet & Machine Co. announced a quarterly cash dividend of $0.03 per share. This is the value of the dividend declared by the company's Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chicago Rivet & Machine Co. published the original content used to generate this news brief via PR Newswire  on November 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL83tsxK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVR","BK4161"],"gpt_icon":0},{"id":"2584670224","title":"Press Release: Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2584670224","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584670224?lang=en_us&edition=fundamental","pubTime":"2025-11-18 07:07","pubTimestamp":1763420820,"startTime":"0","endTime":"0","summary":"--  Halda Therapeutics acquired by Johnson & Johnson for $3.05 billion --. the largest acquisition ever across any therapeutic area for a Phase 1. --  Scorpion Therapeutics acquired by Eli Lilly for Up to $2.5 billion -. one of the highest-value strategic transactions announced in early 2025. Vida Ventures , a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and reinforcing the firm's disciplined, science-first approach to company building and investing.In 2025, four Vida-backed companies were acquired by global pharmaceutical leaders focused on developing new treatments for cancer, autoimmune and neurodegenerative disease. In addition to Halda, Eli Lilly  acquired Scorpion Therapeutics for up to $2.5 billion, adding a next-generation targeted therapy platform to its growing oncology portfolio. Sanofi  completed its acquisition of Vigil Neuroscience for an upfront of $470 mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","LU0882574139.USD","LU1066051225.USD","BK4139","LU1983299246.USD","LU2211815571.USD","R","CVR","LU0353189680.USD","LU1720051017.SGD","SG9999015986.USD","SNY","JNJ","LU0122379950.USD","LU2106854487.HKD","IE00B2B36J28.USD","LU1732799900.SGD","SG9999018857.SGD","IE0002270589.USD","LU0211328371.USD","TM","IE00B19Z3B42.SGD","LLY","LU2168564222.USD","LU1989771016.USD","SGXZ51526630.SGD","LU1804176565.USD","LU0203202063.USD","LU2168563687.JPY","LU1778281490.HKD","LU0965509101.SGD","LU0553294199.USD","LU0106261372.USD","LU1061106388.HKD","LU2168564149.EUR","SG9999001176.SGD","LU0266013472.USD","IE00BSNM7G36.USD","LU1935042991.SGD","LU0320765992.SGD","03160","LU0689626769.HKD","IE00BVYPNW00.USD","LU0203201768.USD","LU2168564495.EUR","LU1917777945.USD","LU1929549753.HKD","SG9999015978.USD","ABBV","LU1244550221.USD"],"gpt_icon":1},{"id":"2584167644","title":"Press Release: Avadel Board of Directors Declares Lundbeck Proposal a \"Company Superior Proposal\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2584167644","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584167644?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:45","pubTimestamp":1763376300,"startTime":"0","endTime":"0","summary":"THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION  596/2014. Lundbeck Proposal Values Avadel at up to $23.00 per Ordinary Share, a Total of Approximately $2.4 billion. Pursuant to Alkermes Transaction Agreement, Avadel and Alkermes May Negotiate Potential Adjustments to Existing Transaction for 5 Business Days. As previously announced, the Lundbeck Proposal provides that Lundbeck would acquire Avadel for up to $23.00 per ordinary share, comprised of  $21.00 per ordinary share in cash at closing and  a non-transferable contingent value right  entitling holders to potential additional cash payments of  $1.00 per ordinary share, contingent upon LUMRYZ and valiloxybate collectively reaching total annual net sales for end-use in the United States of at least $450 million in any calendar year by December 31, 2027 and  $1.00 per ordinary share, contingent upon LUMRYZ and valiloxybate collectively reaching total annual net sales for end-","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4156","BK4099","SPN","BK4555","BK4604","CVR","TM","BK4585","AVDL","BK4588","BK4007","BK4161","03160"],"gpt_icon":0},{"id":"2583563903","title":"Chicago Rivet & Machine Co. Reports Improved Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2583563903","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583563903?lang=en_us&edition=fundamental","pubTime":"2025-11-15 12:15","pubTimestamp":1763180107,"startTime":"0","endTime":"0","summary":"Chicago Rivet & Machine ( ($CVR) ) has released its Q3 earnings. Here is a breakdown of the information Chicago Rivet & Machine presented to its in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chicago-rivet-machine-co-reports-improved-earnings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chicago-rivet-machine-co-reports-improved-earnings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVR"],"gpt_icon":0},{"id":"2583682209","title":"XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2583682209","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583682209?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:51","pubTimestamp":1763157067,"startTime":"0","endTime":"0","summary":"16:47 EST XenoTherapeutics to acquire Repare Therapeutics (RPTX) for $1.82 p/s plus one CVR Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenotherapeutics-to-acquire-repare-therapeutics-for-1-82-p-s-plus-one-cvr-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenotherapeutics-to-acquire-repare-therapeutics-for-1-82-p-s-plus-one-cvr-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RPTX","BK4161","BK4139","CVR"],"gpt_icon":0},{"id":"2583050182","title":"Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2583050182","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583050182?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:30","pubTimestamp":1763127000,"startTime":"0","endTime":"0","summary":"Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024  Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress receive","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/14/3188314/28889/en/Fortress-Biotech-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CVR","FBIO","BK4161"],"gpt_icon":0},{"id":"2583572051","title":"Press Release: Avadel Receives Unsolicited Proposal from Lundbeck","url":"https://stock-news.laohu8.com/highlight/detail?id=2583572051","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583572051?lang=en_us&edition=fundamental","pubTime":"2025-11-14 18:45","pubTimestamp":1763117100,"startTime":"0","endTime":"0","summary":"THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION  596/2014. Lundbeck Reasonably Expected to Result in a \"Company. As previously announced, on October 22, 2025, Avadel entered into a definitive transaction agreement with Alkermes, a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience, under which Alkermes will acquire all outstanding ordinary shares of Avadel . Under the terms of the transaction agreement, Avadel shareholders will receive a total purchase price of up to $20.00 per ordinary share, consisting of $18.50 per ordinary share payable in cash at closing and a CVR of $1.50 per ordinary share, contingent upon final FDA approval of LUMRYZ for the treatment of idiopathic hypersomnia in adults by the end of 2028.Under the transaction agreement with Alkermes, the Avadel Board's deter","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4588","AVDL","BK4156","BK4161","CVR","BK4007","BK4555","TM","BK4585","BK4604","BK4099"],"gpt_icon":0},{"id":"2582237651","title":"Press Release: XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements","url":"https://stock-news.laohu8.com/highlight/detail?id=2582237651","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582237651?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:30","pubTimestamp":1762950600,"startTime":"0","endTime":"0","summary":"Business development: Secures royalty economic interests in two early stage partnered assets through XOMA Royalty's announced expected acquisition of LAVA Therapeutics.Company acquisitions: --Completed XOMA Royalty's acquisitions of Turnstone Biologics and HilleVax; -- announced acquisitions of LAVA Therapeutics and Mural Oncology; -- acted as structuring agent for XenoTherapeutics' acquisition of ESSA Pharma.Key Pipeline advancements: -- Zevra Therapeutics submitted a Marketing Authorization Application  with the European Medicines Agency  seeking marketing approval for arimoclomol as a treatment for Niemann-Pick Type C; -- Rezolute Bio reconfirmed its expectations to announce topline data in December from its Phase 3 ersodetug trial in patients with congenital hyperinsulinism  and announced alignment with FDA on streamlined design for ongoing Phase 3 trial of ersodetug in tumor HI; --Gossamer Bio expects topline results from PROSERA, its Phase 3 trial of seralutunib in pulmonary atri","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","IE00BN0W2T93.GBP","LU0345780521.USD","MAA","LU0345780281.USD","LU0128526141.USD","IE00BN0W2W23.USD","B","BK4232","LU0029874061.USD","HI","LU0498741114.HKD","BK4585","BK4215","LU1721428933.USD","LU0330918003.SGD","LU2125154778.USD","LU2089279066.USD","03160","LU0788108826.HKD","BK4022","BK4567","IE00BN0W2V16.EUR","LU2413666699.HKD","BK4139","LU2092937221.SGD","R","LU0347712357.USD","BK4081","LU0300736492.USD","LU2041044095.USD","LU0075056555.USD","LU2125154935.USD","LU0498741890.SGD","A","LU2413666426.HKD","LU0788109121.HKD","CVR","LU1543694498.USD","LU0300736062.USD","EMA","BK4017","BK4099","BK4555","BK4588","LU1023059493.AUD","TM","LU2229751404.USD","XOMA","LU0368265764.SGD"],"gpt_icon":0},{"id":"2582664508","title":"What CVR Energy (CVI)'s Swing to Profit and New Shelf Offering Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2582664508","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582664508?lang=en_us&edition=fundamental","pubTime":"2025-11-09 00:35","pubTimestamp":1762619731,"startTime":"0","endTime":"0","summary":"CVR Energy, Inc. recently filed a universal shelf registration statement, enabling it to offer a wide range of securities, following its report of third-quarter results with net income of US$374 million compared to a net loss a year earlier and increased refining throughput and production.\nThis marked turnaround in quarterly earnings, alongside higher operating output, highlights improved operational performance and potential strengthening of the company’s financial position.\nLet's explore...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/1033000-choice1-main-header/1585186680256","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/1033000-choice1-main-header/1585186680256"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-cvi/cvr-energy/news/what-cvr-energy-cvis-swing-to-profit-and-new-shelf-offering","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-cvi/cvr-energy/news/what-cvr-energy-cvis-swing-to-profit-and-new-shelf-offering","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4161","CVR","CVI","BK4138"],"gpt_icon":0},{"id":"2581485555","title":"Press Release: Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2581485555","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581485555?lang=en_us&edition=fundamental","pubTime":"2025-11-08 10:32","pubTimestamp":1762569120,"startTime":"0","endTime":"0","summary":"-- Revised transaction values Metsera at up to $86.25 per share. -- Metsera's Board of Directors unanimously recommends that Metsera. stockholders approve the adoption of the amended Pfizer merger agreement. -- Transaction creates real, certain and immediate value for Metsera's. stockholders and ensures Metsera's important drug candidates can emerge. Metsera's Board of Directors unanimously reaffirms its recommendation that the holders of Metsera common stock vote at the special meeting to approve the adoption of the amended Pfizer merger agreement and to approve the merger with Pfizer on the terms and subject to the conditions set forth in the amended Pfizer merger agreement.This release contains forward-looking information about, among other topics, Pfizer's proposed acquisition of Metsera, Pfizer's and Metsera's pipeline products, including their potential benefits, potential best-in-class status, differentiation, profile and dosing, potential clinical trials, and the anticipated ti","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1310ced763b367f15a56d0feccf44e16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","SG9999003800.SGD","LU0306807586.USD","LU0868494617.USD","LU0321505439.SGD","CVR","SG9999002224.SGD","BK4585","LU1057294990.SGD","SG9999001176.SGD","SG9999001176.USD","LU0225284248.USD","IE0002270589.USD","BK4599","MTSR","LU1023059063.AUD","LU0321505868.SGD","BK4568","LU0985481810.HKD","LU0225771236.USD","LU1066051498.USD","BK4581","BK4592","LU1894683348.USD","BK4588","BK4533","LU0170899867.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0122379950.USD","IE00BLSP4452.SGD","LU1894683264.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","SG9999002232.USD","BK4139","LU1066053197.SGD","LU0306806265.USD","BK4550","PFE","SG9999013999.USD","BK4161","BK4007","LU0456855351.SGD","BK4534","LU0289739699.SGD","SG9999011175.SGD","LU1883839398.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2581834579","title":"Chicago Rivet & Machine Co. posts third quarter net income of $67,572 on sales of $7.36 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834579","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581834579?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:45","pubTimestamp":1762551927,"startTime":"0","endTime":"0","summary":"Chicago Rivet & Machine Co. reported third quarter 2025 net sales of $7.4 million, up from $7.0 million in the same period of 2024. Net income for the quarter was $67,600, compared to a net loss of $1.4 million in the third quarter of 2024. For the first nine months of 2025, net sales reached $21.9 million, down from $22.9 million for the same period in 2024. Net income for the first nine months was $73,600, compared to a net loss of $2.0 million in the prior year period. Net income per common share for the third quarter was $0.07, versus a net loss of $1.50 per share in the previous year. Average common shares outstanding for the period were 966,132.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chicago Rivet & Machine Co. published ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL8PlfpP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVR","BK4161"],"gpt_icon":0},{"id":"2581834697","title":"Chicago Rivet & Machine Co. Announces Third Quarter Results of Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581834697?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:45","pubTimestamp":1762551900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUABLQPN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4161","CVR"],"gpt_icon":0},{"id":"2581769640","title":"Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581769640","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581769640?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:01","pubTimestamp":1762290060,"startTime":"0","endTime":"0","summary":"– Generated LUMRYZ net product revenue of $77.5 million, a 55% increase compared to third quarter 2024 – – Approximately 3,400 patients on LUMRYZ as of September 30, 2025, a 48% increase compared to S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180824/0/en/Avadel-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4215","CNS","PK","BK4218","BK4135","BK4588","BK4597","BK4585","ESS","BK4161","BK4181","CVR"],"gpt_icon":0},{"id":"1138075250","title":"CVR Partners Q3 2025 Earnings Call Summary and Q&A Highlights: Strong Pricing and Strategic Projects Drive Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1138075250","media":"Earnings Call","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138075250?lang=en_us&edition=fundamental","pubTime":"2025-11-02 04:55","pubTimestamp":1762030556,"startTime":"0","endTime":"0","summary":"[Management View]Net sales for Q3 2025 were $164 million, driven by higher UAN and ammonia pricing. Net income was $43 million, or $4.02 per common unit. EBITDA was $71 million, reflecting higher...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVR","UAN"],"gpt_icon":0},{"id":"2580790784","title":"CVR Partners (UAN) Q3 2025 Earnings Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2580790784","media":"Motley Fool Transcribing","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580790784?lang=en_us&edition=fundamental","pubTime":"2025-11-02 04:53","pubTimestamp":1762030382,"startTime":"0","endTime":"0","summary":"DATEThursday, Oct. 30, 2025, at 11 a.m. ETCALL PARTICIPANTSChief Executive Officer — Mark PytoshChief Financial Officer — Dane NeumannExecutive Vice President, Corporate Affairs — Richard RobertsNeed a quote from a Motley Fool analyst?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_motley_transcript","url":"https://www.fool.com/earnings/call-transcripts/2025/11/01/cvr-partners-uan-q3-2025-earnings-transcript/","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2025/11/01/cvr-partners-uan-q3-2025-earnings-transcript/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["CVR","UAN"],"gpt_icon":0},{"id":"2580416038","title":"CVR Energy files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416038","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416038?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:35","pubTimestamp":1761942912,"startTime":"0","endTime":"0","summary":"16:34 EDT CVR Energy (CVI) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cvr-energy-files-automatic-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cvr-energy-files-automatic-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4138","CVI","CVR","BK4161"],"gpt_icon":0},{"id":"2579248986","title":"How Strong Q3 Results and Higher Dividend Will Impact CVR Partners (UAN) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2579248986","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579248986?lang=en_us&edition=fundamental","pubTime":"2025-10-31 06:39","pubTimestamp":1761863977,"startTime":"0","endTime":"0","summary":"CVR Partners, LP reported much stronger third quarter 2025 financial results on October 29, with sales rising to US$163.55 million and net income reaching US$43.07 million compared to a year earlier.\nThe company also announced a significant increase in its quarterly cash distribution to US$4.02 per common unit, highlighting increased returns for shareholders.\nWe'll explore how the impressive growth in earnings and higher dividend shapes CVR Partners' investment narrative going forward.\nWe've...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-uan/cvr-partners/news/how-strong-q3-results-and-higher-dividend-will-impact-cvr-pa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-uan/cvr-partners/news/how-strong-q3-results-and-higher-dividend-will-impact-cvr-pa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4590","ISBC","UAN","BK4211","BK4161","CVR","BK4093"],"gpt_icon":0},{"id":"2579213110","title":"CVR Partners Reports Strong Q3 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579213110","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579213110?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:54","pubTimestamp":1761771265,"startTime":"0","endTime":"0","summary":"CVR Partners ( ($UAN) ) has issued an announcement. CVR Partners reported strong financial results for the third quarter of 2025, with a net income...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cvr-partners-reports-strong-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cvr-partners-reports-strong-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVR","BK4161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chicagorivet.com","stockEarnings":[{"period":"1week","weight":0.3086},{"period":"1month","weight":0.5346},{"period":"3month","weight":0.4689},{"period":"6month","weight":0.06},{"period":"1year","weight":-0.1276},{"period":"ytd","weight":-0.0912}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Chicago Rivet & Machine Co. operates in the fastener industry in North America. The company operates in two segments, Fasteners and Assembly Equipment. The Fastener segment manufactures and sells rivets, cold-formed fasteners and parts, and screw machine products. The Assembly Equipment segment manufactures and sells automatic rivet setting machines and assembly equipment, as well as parts and tools for related machines. It sells its products to automobile and automotive component manufacturers through independent sales representatives. The company was founded in 1920 and is headquartered in Naperville, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.755556,"avgChangeRate":0.045711},{"month":2,"riseRate":0.688889,"avgChangeRate":0.020881},{"month":3,"riseRate":0.4,"avgChangeRate":0.012556},{"month":4,"riseRate":0.478261,"avgChangeRate":0.004079},{"month":5,"riseRate":0.434783,"avgChangeRate":-0.005572},{"month":6,"riseRate":0.413043,"avgChangeRate":-0.003846},{"month":7,"riseRate":0.5,"avgChangeRate":0.015237},{"month":8,"riseRate":0.369565,"avgChangeRate":-0.01643},{"month":9,"riseRate":0.413043,"avgChangeRate":-0.004326},{"month":10,"riseRate":0.478261,"avgChangeRate":0.002774},{"month":11,"riseRate":0.369565,"avgChangeRate":-0.004407},{"month":12,"riseRate":0.413043,"avgChangeRate":-0.009826}],"exchange":"AMEX","name":"Chicago Rivet & Machine","nameEN":"Chicago Rivet & Machine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chicago Rivet & Machine(CVR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Chicago Rivet & Machine(CVR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Chicago Rivet & Machine,CVR,Chicago Rivet & Machine股票,Chicago Rivet & Machine股票老虎,Chicago Rivet & Machine股票老虎国际,Chicago Rivet & Machine行情,Chicago Rivet & Machine股票行情,Chicago Rivet & Machine股价,Chicago Rivet & Machine股市,Chicago Rivet & Machine股票价格,Chicago Rivet & Machine股票交易,Chicago Rivet & Machine股票购买,Chicago Rivet & Machine股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chicago Rivet & Machine(CVR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Chicago Rivet & Machine(CVR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}